Latest News

MediSieve expands its research into treating COVID-19

MediSieve expands its research into treating COVID-19
April 29, 2020

Recent studies show that patients with the most serious forms of the coronavirus had high levels of something called IL-6, a common inflammatory cytokine, which MediSieve has previously encountered while researching sepsis and cytokine storms.
COVID-19 Response

COVID-19 Response
April 03, 2020

Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine storm syndromes, and that these are a major driver of mortality.